13296.
Clinical safety and pharmacokinetic evaluation of aqueous extract of Cocculus hirsutus, an anti-viral phytopharmacetical drug as a potential for the treatment of dengue and COVID-19.
Scientists have conducted a study on AQCH tablets as a potential treatment for dengue and COVID-19 infections. The study aimed to evaluate the safety and pharmacokinetics of AQCH in healthy human subjects. AQCH has shown to have anti-viral activity in in vitro and small animal studies. With no effective vaccine or drug available for dengue, this study brings hope for a potential treatment option. The results of this study suggest that AQCH tablets are safe and well-tolerated in humans, and could be a promising solution in the fight against dengue and COVID-19.
Dar SK et al (2022).
Heliyon.